Page last updated: 2024-10-22

alfuzosin and Dermatomyositis

alfuzosin has been researched along with Dermatomyositis in 2 studies

alfuzosin: structure given in first source

Dermatomyositis: A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vela-Casasempere, P1
Borras-Blasco, J1
Navarro-Ruiz, A1
Navarro-Blasco, FJ1

Other Studies

2 other studies available for alfuzosin and Dermatomyositis

ArticleYear
Alfuzosin-associated dermatomyositis.
    British journal of rheumatology, 1998, Volume: 37, Issue:10

    Topics: Adrenergic alpha-Antagonists; Aged; Dermatomyositis; Humans; Magnetic Resonance Imaging; Male; Muscl

1998
Alfuzosin is not associated with dermatomyositis.
    Rheumatology (Oxford, England), 1999, Volume: 38, Issue:6

    Topics: Adrenergic alpha-Antagonists; Carcinoma; Dermatomyositis; Humans; Lung Neoplasms; Male; Quinazolines

1999